logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Value in Health cover

Value in Health

IF6
Papers44465
Citations14954
Journal Papers 70281
Publication Date
delete
Health Utilities and Costs for Multiple Sclerosis
deleteValue in Health
IF6
delete2026-10-07
delete0
deleteOAAI
deleteYankier Pijeira Perez; Carolyn A. Young; Roger J. Mills; Dyfrig A. Hughes
deleteShare
deleteSave
Reconciling Conflicting Evidence on Peri–Immune Checkpoint Inhibitor COVID-19 mRNA Vaccination in Lung Cancer: A Time-Aligned Target Trial Emulation–Informed Landmark Study
deleteValue in Health
IF6
delete2026-10-06
delete0
PREAI
deleteShih-Sen Lin; Ju-Fang Liu; Pei-Sung Hsu; Hung-Chi Lai; Wen-Pin Cheng
deleteShare
deleteSave
Assessing the Value of Digital Health Interventions: A Systematic Review of Evaluation Frameworks and Approaches, Key Dimensions and Criteria
deleteValue in Health
IF6
delete2026-10-06
delete0
deleteOAAI
deleteAnn-Kathrin Fischer; Axel Mühlbacher
deleteShare
deleteSave
Evaluating the cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care: the UK-ROX trial
deleteValue in Health
IF6
delete2026-10-01
delete0
deleteOAAI
deleteZhengnan Zhu; Daniel Martin; Alex Cowden; Doug Gould; Michael P.W. Grocott; Tasnin Shahid; David Harrison; Kathryn M. Rowan; Paul Mouncey; Zia Sadique
deleteShare
deleteSave
Estimating the Wider Societal Impact of Semaglutide Across Multiple Indications in Canada: an Economic Evaluation
deleteValue in Health
IF6
delete2026-09-29
delete0
deleteOAAI
deleteDon Husereau; Marc Evans; Julie Hviid Hahn-Pedersen; Robert King; Jamie Kettle; Bejamin D. Bray; Marina Berger; Maria Luckevich; Christopher Lübker; Soeren Mattke
deleteShare
deleteSave
Barriers and facilitators to implementing patient-reported outcome and experience measures (PROMs/PREMs) in health systems: a comprehensive overview of systematic reviews
deleteValue in Health
IF6
delete2026-09-28
delete0
deleteOAAI
deleteGuillaume Fontaine; Meagan Mooney; Joshua Ramos; Laura Crump; Marie-Eve Perron; Marie-Eve Poitras; Maxime Sasseville; Rachael Laritz; Lydia Ould Brahim; ; Sylvie D. Lambert
deleteShare
deleteSave
Recommendations on the Implementation of Performance Outcome Assessments in Clinical Trials: A Good Practices Report of an ISPOR Task Force
deleteValue in Health
IF6
delete2026-09-28
delete0
PREAI
deleteElizabeth (Nicki) Bush; Chris J. Edgar; Heather Adams; Alexandra Atkins; Bill Byrom; Michelle Campbell; Heather Dickerson; Sonya Eremenco; Naomi Knoble; Fiona McDougall; Elektra Papadopoulos; Ashley F. Slagle
deleteShare
deleteSave
Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom MeasureValue Health. 2019;22(8):906-915.
deleteValue in Health
IF6
delete2026-09-26
delete0
PREAI
deleteDonald M. Bushnell; Kelly P. McCarrier; Elizabeth Nicole Bush; Lucy Abraham; Carol Jamieson; Fiona McDougall; Madhukar H. Trivedi; Michael E. Thase; Linda Carpenter; Stephen Joel Coons
deleteShare
deleteSave
Signaling Demand with Cost-Effectiveness Analysis: A Case Study of PCSK9 Inhibitors
deleteValue in Health
IF6
delete2026-09-25
delete0
PREAI
deleteCiaran N. Kohli-Lynch; Yina M. Quique; Andrew H. Briggs
deleteShare
deleteSave
Sources of the utilities used in paediatric cost-utility analyses in children aged under 5 years, and the methods used in their elicitation: a systematic review
deleteValue in Health
IF6
delete2026-09-24
delete0
deleteOAAI
deleteAlexander van Heusden; Ashwini De Silva; Sophie ten Dam; Vercancy Wu; Wendy J. Ungar; Nancy Devlin; Kim Dalziel
deleteShare
deleteSave
CONFIRMATORY VALIDATION AND CLUSTER CLASSIFICATION OF THE IRRITABLE BOWEL SYNDROME SYMPTOM SEVERITY SCALE (IBS-SSS)
deleteValue in Health
IF6
delete2026-09-23
delete0
deleteOAAI
deletePragalathan Apputhurai; Olafur S. Palsson; Shrikant I. Bangdiwala; Ami D. Sperber; Antonina Mikocka-Walus; Simon R. Knowles
deleteShare
deleteSave
Cost-Effectiveness Analysis of the Five First-line Treatment Regimens for ALK-positive NSCLC in China: An Economic Evaluation Based on Network Meta-Analysis
deleteValue in Health
IF6
delete2026-09-21
delete0
deleteOAAI
deleteHui Zhang; Shuangshuang Hu; Yuhang Liu; Jing Ou; Bikun Cai; Guihao Zeng
deleteShare
deleteSave
The Implementation of NICE Severity Modifier in the Single Technology Appraisal of Mirvetuximab Soravtansine: External Assessment Group Perspective
deleteValue in Health
IF6
delete2026-09-21
delete0
PREAI
deleteAhmed Abdelsabour; Jemma Perks; Charlotte Kelman; Sophie Robinson; Caroline Farmer; Dawn Lee
deleteShare
deleteSave
Generative Artificial Intelligence for Systematic Literature Reviews: A Good Practices Report of an ISPOR Special Task Force
deleteValue in Health
IF6
delete2026-09-19
delete0
PREAI
deleteRachael L. Fleurence; Riaz Qureshi; Rakesh Aggarwal; Jiang Bian; Dalia Dawoud; Diana Delnoij; Ruth R. Faden; Sven Klijn; Raphael Sonabend; Jagpreet Chhatwal
deleteShare
deleteSave
Health Technology Assessment Lifecycle Concepts: A Scoping Review Outlining the Change in Policies to Manage Uncertainties Associated With Reimbursement of Medicines
deleteValue in Health
IF6
delete2026-09-16
delete0
deleteOAAI
deleteJelle Stoelinga; Carla E. Hollak; Lonneke Timmers; Wim G. Goettsch; Christine Leopold
deleteShare
deleteSave
Cost-Effectiveness of Cilta-cel in Lenalidomide-Refractory Multiple Myeloma: An Analysis of the CARTITUDE-4 Trial
deleteValue in Health
IF6
delete2026-09-11
delete0
PREAI
deleteYanxiao Zhang; Yabei Li; Jianhua Chen; Guojun Sun; Yiman Zhang
deleteShare
deleteSave
An Application of Iterative Health Economic Evaluation: An Update on the Early Cost Effectiveness of Whole-Genome Sequencing in Advanced Non-small-Cell Lung Cancer
deleteValue in Health
IF6
delete2026-09-09
delete0
PREAI
deleteAndrea Fernández Coves; Bram Ramaekers; Martijn Simons; Lucas F. van Schaik; Sabine Grimm; Valesca P. Retèl; Manuela Joore
deleteShare
deleteSave
Does conventional cost-effectiveness analysis disadvantage treatments for severe disease? Evidence from U.S. value assessments
deleteValue in Health
IF6
delete2026-09-08
delete0
PREAI
deleteAntal T. Zemplenyi; R. Brett McQueen; Harry Gyimah Gyamfi; Deepika Paratane; Michael J. DiStefano
deleteShare
deleteSave
The Application of FDA Patient-Focused Drug Development Guidance in Rare Patient Populations: Innovation and Flexibility
deleteValue in Health
IF6
delete2026-09-07
delete0
PREAI
deleteStacie Hudgens
deleteShare
deleteSave
Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65 to 69 Years (CAREMM-2110 Study)
deleteValue in Health
IF6
delete2026-09-01
delete0
PREAI
deleteLee, Jung Yeon; Jung, Seungpil; Park, Sung-Soo; Byeon, Seonggyu; Shin, Seung-Hwan; Jeon, Young-Woo; Yahng, Seung-Ah; Choi, Suein; Kim, Jin Seok; Min, Chang-Ki
deleteShare
deleteSave